Nemariam Mesfin - Profile and Investment Details

Investor Profile

Nemariam Mesfin is a Corporate Venture Capital based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as iRhythm Technologies, Arcxis Biotechnologies, Kit Check, IntelyCare, Astute Medical, Hemosphere, Proteus Digital Health, TriVascular, Nordic, Xanitos, Ingenious Med, Freenome, CytoPherx, CHF Solutions, Collective Medical Technologies, CareGuardian, Everytable, NextWeb, Valeritas, Big Health, Zonare Medical Systems, Vesta Healthcare, Arbor Surgical Technologies, MetricStream, Movable, GluMetrics, Vidyo, Chrono Therapeutics, Accumetrics, Oxford Immunotec, Genome Medical, Bacchus Vascular, Omada Health, Torax MedicalAgile Therapeutics, Ordr, Kate Farms, Adiana, ValenTx, Nuvolo, DexCare, Radianse, Evidation Health, Transcend Medical, Calypso Medical, Osso VR, Health Catalyst, Ginger, Validic, Kaiser Permanente Ventures, NeoGuide Systems, Vapotherm, Protenus, BDNA, AtheroMed, Predictive Biosciences, Baxano, . Over time, Nemariam Mesfin has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Nemariam Mesfin is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Genetics, Healthcare Delivery, Wellness, Women Founded, Enterprise Software, Investment Management, Healthcare Innovation, Life Science, Health Technology, Health Care Policy, Information Services, Analytics, Software, Biotechnology, Virtual Reality, Genomics, Nutrition, Food and Beverage, Clinical Trials, Research, Facility Management, Health Diagnostics, Digital Health, Developer Tools, Medical, Big Data, Therapeutics, Personal Health, Business Intelligence may find it worthwhile to explore potential connections with Nemariam Mesfin, as their portfolio suggests a familiarity and interest in this area.

Understanding Nemariam Mesfin’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.